Malignant pleural mesothelioma: initial experience in integrated (18)F-FDG PET/MR imaging

Benedikt M Schaarschmidt1, Lino M Sawicki2, Benedikt Gomez3

  • 1University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, D-40225 Dusseldorf, Germany; University Duisburg-Essen, Medical Faculty, Department of Diagnostic and Interventional Radiology and Neuroradiology, D-45147 Essen, Germany.

Clinical Imaging
|May 28, 2016
PubMed
Abstract

Insights

Integrated PET/MR staging for malignant pleural mesothelioma (MPM) is comparable to PET/CT. A significant inverse correlation between apparent diffusion coefficient (ADC) and standardized uptake value (SUV) suggests potential for multiparametric response assessment.

Area of Science:

  • Oncology
  • Radiology
  • Medical Imaging

Background:

  • Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer.
  • Accurate staging is crucial for treatment planning and prognosis in MPM.
  • Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) is a standard imaging modality for MPM staging.

Purpose of the Study:

  • To compare the staging accuracy of integrated (18)F-FDG PET/CT and PET/Magnetic Resonance (MR) imaging in patients with MPM.
  • To investigate the correlation between apparent diffusion coefficient (ADC) and standardized uptake value (SUV) in MPM lesions.

Main Methods:

  • Six patients diagnosed with MPM underwent both (18)F-FDG PET/CT and integrated PET/MR imaging, including diffusion-weighted imaging (DWI).
  • Thoracic TNM staging was performed independently for both imaging modalities.
  • SUVmax and ADCmin values were quantified in therapy-naive pleural lesions.

Main Results:

  • No significant differences were observed in thoracic TNM staging between PET/CT and PET/MR.
  • A statistically significant inverse correlation was found between mean SUV (SUVmean) and minimum ADC (ADCmin) (r=-0.63, P=.002).

Conclusions:

  • Integrated PET/MR imaging is a feasible and effective tool for staging malignant pleural mesothelioma.
  • The observed inverse correlation between ADC and SUV suggests that multiparametric imaging may offer new insights into therapy response evaluation in MPM.

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
616
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
8.0K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
729